Analysis reveals marker genes in immune clusters from melanoma patients, suggesting NK cells affect immunotherapy outcomes.
Discriminatory marker genes of all immune clusters obtained by summarising unsupervised Louvain clustering and subclustering of myeloid, and CD8+T/NK cells.
No takes yet. Share an insight, caveat, or question.
Poźniak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: